Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Denali Therapeutics Inc
Swot
Denali Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Denali Therapeutics Inc has 7 Strengths, 14 Weaknesses, 2 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(7)
Weakness
(14)
Opportunity
(2)
Threats
(3)
Others
(0)
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Company with Low Debt
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Red Flags: Weakening Technicals and Share Price Decline
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
